Augmont Enterprises Limited has officially confirmed that the proceeds from its public issue, amounting to ₹620 crore and raised on 27/08/2026, have been utilized precisely as stated in the offer document for the quarter ended 30th September 2026. The company has declared no material deviation in the use of these funds, ensuring compliance with regulatory requirements.
Public Issue Fund Utilization Statement
Augmont Enterprises Limited, formerly known as Augmont Enterprises Private Limited, has submitted a statement regarding the utilization of funds raised through its public issue. The company raised a total of ₹620 crore on 27th August 2026. For the quarter ending 30th September 2026, Augmont Enterprises Limited has affirmed that the funds were used for the purposes outlined in the original offer document.
Regulatory Compliance
In accordance with Regulation 32(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company hereby declares that there has been no material deviation in the use of proceeds from the public issue compared to the stated objects. This statement has been reviewed and approved by the Audit Committee and the Board of Directors of the Company at their respective meetings held on 04th November 2026.
Fund Allocation Details
The statement, enclosed as Annexure A, details the fund allocation and utilization. For funding future working capital requirements, procurement, maintenance, and scaling up of inventory, an allocation of ₹465 crore was made, with ₹465.23 crore utilized, showing a deviation of ₹0.00 crore. General Corporate Purposes saw an allocation of ₹107.76 crore, with the same amount utilized. Offer expenses involved an allocation of ₹47.24 crore, with ₹46.60 crore utilized, indicating a deviation of ₹0.41 crore.
Source: BSE
